Literature DB >> 11596658

PKU adults and their return to diet: predicting diet continuation and maintenance.

L Finkelson1, I Bailey, S E Waisbren.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11596658     DOI： 10.1023/a:1010546000617

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  1 in total

Review 1.  PKU in adolescents: rationale and psychosocial factors in diet continuation.

Authors:  H L Levy; S E Waisbren
Journal:  Acta Paediatr Suppl       Date:  1994-12
  1 in total
  10 in total

1.  Practical aspects of recruitment and retention in clinical trials of rare genetic diseases: the phenylketonuria (PKU) experience.

Authors:  Stephanie J DeWard; Ashley Wilson; Heather Bausell; Ashley S Volz; Kimberly Mooney
Journal:  J Genet Couns       Date:  2013-09-08       Impact factor: 2.537

2.  BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up.

Authors:  Rani H Singh; Meghan E Quirk; Teresa D Douglas; Mary C Brauchla
Journal:  J Inherit Metab Dis       Date:  2010-10-13       Impact factor: 4.982

Review 3.  The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.

Authors:  F J van Spronsen; P Burgard
Journal:  J Inherit Metab Dis       Date:  2008-08-12       Impact factor: 4.982

Review 4.  Large neutral amino acids supplementation in phenylketonuric patients.

Authors:  J C Rocha; F Martel
Journal:  J Inherit Metab Dis       Date:  2009-05-13       Impact factor: 4.982

5.  Relationships Between Childhood Experiences and Adulthood Outcomes in Women with PKU: A Qualitative Analysis.

Authors:  Rachel M Roberts; Tamara Muller; Annabel Sweeney; Drago Bratkovic; Anne Gannoni; Brianna Morante
Journal:  JIMD Rep       Date:  2016-06-14

6.  The Resource Mothers Study of Maternal Phenylketonuria: preliminary findings.

Authors:  F Rohr; A Munier; D Sullivan; I Bailey; M Gennaccaro; H Levy; H Brereton; S Gleason; B Goss; E Lesperance; K Moseley; R Singh; L Tonyes; H Vespa; S Waisbren
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

7.  Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria.

Authors:  Deborah A Bilder; Georgianne L Arnold; David Dimmock; Mitzie L Grant; Darren Janzen; Nicola Longo; Mina Nguyen-Driver; Elaina Jurecki; Markus Merilainen; Gianni Amato; Susan Waisbren
Journal:  Am J Med Genet A       Date:  2021-11-26       Impact factor: 2.578

Review 8.  Recommendations for the nutrition management of phenylalanine hydroxylase deficiency.

Authors:  Rani H Singh; Fran Rohr; Dianne Frazier; Amy Cunningham; Shideh Mofidi; Beth Ogata; Patricia L Splett; Kathryn Moseley; Kathleen Huntington; Phyllis B Acosta; Jerry Vockley; Sandra C Van Calcar
Journal:  Genet Med       Date:  2014-01-02       Impact factor: 8.822

Review 9.  Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.

Authors:  Deborah A Bilder; J Kay Noel; Erin R Baker; William Irish; Yinpu Chen; Markus J Merilainen; Suyash Prasad; Barbara J Winslow
Journal:  Dev Neuropsychol       Date:  2016-11-02       Impact factor: 2.253

10.  The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study.

Authors:  Nicholas M Burgess; Wendy Kelso; Charles B Malpas; Toby Winton-Brown; Timothy Fazio; Julie Panetta; Gerard De Jong; Joanna Neath; Sonny Atherton; Dennis Velakoulis; Mark Walterfang
Journal:  Orphanet J Rare Dis       Date:  2021-01-18       Impact factor: 4.123
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.